INS and Parkinson disease: The focus of this review is therefore to characterize the current literature on the role of insulin in CNS disorders, with a focus on traumatic brain injury (TBI), spinal cord injury (SCI), and neurodegenerative diseases, specifically Alzheimer’s disease (AD) and Parkinson’s disease (PD).